Cargando…

Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer

Metabolomic analysis has proven to be a useful tool in biomarker discovery and the molecular classification of cancers. In order to find new biomarkers, and to better understand its pathological behavior, bladder cancer also has been studied using a metabolomics approach. In this article, we review...

Descripción completa

Detalles Bibliográficos
Autores principales:	di Meo, Nicola Antonio, Loizzo, Davide, Pandolfo, Savio Domenico, Autorino, Riccardo, Ferro, Matteo, Porta, Camillo, Stella, Alessandro, Bizzoca, Cinzia, Vincenti, Leonardo, Crocetto, Felice, Tataru, Octavian Sabin, Rutigliano, Monica, Battaglia, Michele, Ditonno, Pasquale, Lucarelli, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030452/ https://www.ncbi.nlm.nih.gov/pubmed/35456991 http://dx.doi.org/10.3390/ijms23084173

Ejemplares similares

Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
por: di Meo, Nicola Antonio, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Novel Insights into Autophagy and Prostate Cancer: A Comprehensive Review
por: Loizzo, Davide, et al.
Publicado: (2022)

Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma
por: Lasorsa, Francesco, et al.
Publicado: (2023)

MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome
por: Lucarelli, Giuseppe, et al.
Publicado: (2022)

Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Current Management of Urachal Carcinoma: An Evidence-based Guide for Clinical Practice
por: Loizzo, Davide, et al.
Publicado: (2022)

Integration of Lipidomics and Transcriptomics Reveals Reprogramming of the Lipid Metabolism and Composition in Clear Cell Renal Cell Carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2020)

Radiogenomics in Renal Cancer Management—Current Evidence and Future Prospects
por: Ferro, Matteo, et al.
Publicado: (2023)

Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics
por: Ragone, Rosa, et al.
Publicado: (2016)

Emerging Urinary Markers of Renal Injury in Obstructive Nephropathy
por: Lucarelli, Giuseppe, et al.
Publicado: (2014)

The Impact of Meat Intake on Bladder Cancer Incidence: Is It Really a Relevant Risk?
por: Aveta, Achille, et al.
Publicado: (2022)

The Efficacy of Flogofilm(®) in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
por: Barone, Biagio, et al.
Publicado: (2023)

MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation
por: Lucarelli, Giuseppe, et al.
Publicado: (2023)

Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2015)

A Rare Case of Solitary Fibrous Tumour of the Pelvis in an 18-Year-Old Young Man: CT and MRI Features with Pathologic Correlations
por: Ascione, Raffaele, et al.
Publicado: (2020)

Use of Intravesical Injections of Platelet-Rich Plasma for the Treatment of Bladder Pain Syndrome: A Comprehensive Literature Review
por: Trama, Francesco, et al.
Publicado: (2021)

Modified Technique for Wirsung-Pancreatogastric Anastomosis after Pancreatoduodenectomy: A Single Center Experience and Systematic Review of the Literature
por: Bizzoca, Cinzia, et al.
Publicado: (2021)

8-Hydroxy-2-Deoxyguanosine and 8-Iso-Prostaglandin F2α: Putative Biomarkers to assess Oxidative Stress Damage Following Robot-Assisted Radical Prostatectomy (RARP)
por: Di Minno, Alessandro, et al.
Publicado: (2022)

Robotic partial nephrectomy for large renal Leiomyoma: first case report
por: Franco, Antonio, et al.
Publicado: (2023)

Molecular Imaging Diagnosis of Renal Cancer Using (99m)Tc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques
por: Tataru, Octavian Sabin, et al.
Publicado: (2023)

Erectile and sexual dysfunction in male and female patients with celiac disease: A cross‐sectional observational study
por: Romano, Lorenzo, et al.
Publicado: (2022)

Radiomics in prostate cancer: an up-to-date review
por: Ferro, Matteo, et al.
Publicado: (2022)

The effects of somatostatin analogues on liver volume and quality of life in polycystic liver disease: a meta-analysis of randomized controlled trials
por: Garofalo, Carlo, et al.
Publicado: (2021)

Prostate Cancer Radiogenomics—From Imaging to Molecular Characterization
por: Ferro, Matteo, et al.
Publicado: (2021)

Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review
por: Ferro, Matteo, et al.
Publicado: (2023)

Clinical factors affecting prostate-specific antigen levels in prostate cancer patients undergoing radical prostatectomy: a retrospective study
por: Tarantino, Giovanni, et al.
Publicado: (2021)

Radiotherapy to the Primary Tumor: The First Step of a Tailored Therapy in Metastatic Prostate Cancer
por: Ferro, Matteo, et al.
Publicado: (2022)

Association of NAFLD and Insulin Resistance with Non Metastatic Bladder Cancer Patients: A Cross-Sectional Retrospective Study
por: Tarantino, Giovanni, et al.
Publicado: (2021)

The impact the COVID-19 pandemic on urology literature: a bibliometric analysis
por: Crocerossa, Fabio, et al.
Publicado: (2022)

Fascin-1 and its role as a serological marker in prostate cancer: a prospective case–control study
por: Tătaru, Octavian Sabin, et al.
Publicado: (2021)

Diagnostic and Prognostic Role of Preoperative Circulating CA 15-3, CA 125, and Beta-2 Microglobulin in Renal Cell Carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2014)

Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2018)

Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature
por: Crocetto, Felice, et al.
Publicado: (2021)

Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma
por: Vavallo, Antonio, et al.
Publicado: (2014)

Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma
por: Gigante, Margherita, et al.
Publicado: (2015)

Penile prosthesis implant for primary erectile dysfunction in patient with Klippel-Trenaunay syndrome complicated by consumptive coagulopathy: A case report
por: Bettocchi, Carlo, et al.
Publicado: (2019)

The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma
por: De Palma, Giuseppe, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_h9cbn2veh0rfge8u3si44mj3ga